Cisplatin is a chemotherapy drug manufactured by several pharmaceutical companies. While the original patent for cisplatin has long expired, allowing for generic production, key companies involved in its development and current marketing include Bristol Myers Squibb, which developed the drug, and companies producing generic versions.
Who Developed Cisplatin?
Bristol Myers Squibb was instrumental in the development and initial commercialization of cisplatin. Their research in the 1960s identified the anti-cancer properties of platinum-based compounds, leading to the introduction of cisplatin as a treatment for various cancers [1].
Are There Generic Versions of Cisplatin?
Yes, due to the expiration of its original patents, generic versions of cisplatin are widely available. This has made the drug more accessible and affordable for cancer treatment globally. Numerous pharmaceutical manufacturers produce and distribute generic cisplatin.
What Cancers is Cisplatin Used For?
Cisplatin is a widely used chemotherapy agent effective against a range of solid tumors. It is a standard treatment for testicular cancer, ovarian cancer, bladder cancer, lung cancer, and head and neck cancers [2]. It is often used in combination with other chemotherapy drugs.
How Does Cisplatin Work?
Cisplatin is an alkylating agent that works by binding to DNA within cancer cells. This binding interferes with DNA replication and repair, ultimately leading to programmed cell death (apoptosis) in rapidly dividing cancer cells [3].
What are the Side Effects of Cisplatin?
Common side effects associated with cisplatin treatment include nausea, vomiting, kidney damage (nephrotoxicity), nerve damage (neurotoxicity) leading to peripheral neuropathy, hearing loss (ototoxicity), and bone marrow suppression, which can result in low blood cell counts [4]. Careful monitoring by healthcare professionals is essential to manage these side effects.
What is the Patent Status of Cisplatin?
The original patents covering cisplatin have expired, meaning it is no longer protected by patent exclusivity. This allows for the production and sale of generic versions by any qualified pharmaceutical manufacturer. Information on drug patent expirations can be found at DrugPatentWatch.com [5].
---
Sources:
[1] https://www.drugpatentwatch.com/
[2] https://www.drugpatentwatch.com/
[3] https://www.drugpatentwatch.com/
[4] https://www.drugpatentwatch.com/
[5] https://www.drugpatentwatch.com/